Cabot Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.54M Sell
8,200
-174
-2% -$176K 0.87% 43
2025
Q4
$9M Sell
8,374
-248
-3% -$237K 0.99% 39
2025
Q3
$6.58M Sell
8,622
-35
-0.4% -$26K 0.73% 49
2025
Q2
$6.75M Sell
8,657
-65
-0.7% -$50.5K 0.8% 45
2025
Q1
$7.2M Buy
8,722
+2,367
+37% +$1.97M 0.92% 41
2024
Q4
$4.91M Buy
6,355
+107
+2% +$88.6K 0.62% 51
2024
Q3
$5.54M Sell
6,248
-186
-3% -$167K 0.69% 46
2024
Q2
$5.83M Buy
6,434
+6
+0.1% +$4.8K 0.76% 46
2024
Q1
$5M Sell
6,428
-166
-3% -$118K 0.65% 46
2023
Q4
$3.84M Sell
6,594
-39
-0.6% -$22.8K 0.53% 51
2023
Q3
$3.56M Buy
6,633
+4,708
+245% +$2.43M 0.55% 52
2023
Q2
$903K Hold
1,925
0.13% 95
2023
Q1
$661K Hold
1,925
0.1% 102
2022
Q4
$704K Sell
1,925
-940
-33% -$333K 0.12% 97
2022
Q3
$926K Hold
2,865
0.16% 93
2022
Q2
$929K Hold
2,865
0.15% 95
2022
Q1
$820K Hold
2,865
0.11% 101
2021
Q4
$791K Hold
2,865
0.1% 103
2021
Q3
$662K Hold
2,865
0.09% 109
2021
Q2
$658K Hold
2,865
0.09% 106
2021
Q1
$535K Buy
2,865
+661
+30% +$129K 0.08% 107
2020
Q4
$372K Buy
2,204
+279
+14% +$41.7K 0.06% 117
2020
Q3
$285K Buy
1,925
+84
+5% +$13K 0.05% 120
2020
Q2
$302K Hold
1,841
0.06% 111
2020
Q1
$255K Hold
1,841
0.06% 105
2019
Q4
$242K Hold
1,841
0.05% 117
2019
Q3
$206K Hold
1,841
0.04% 128
2019
Q2
$204K Hold
1,841
0.04% 126
2019
Q1
$239K Sell
1,841
-159
-8% -$19.3K 0.05% 122
2018
Q4
$231K Hold
2,000
0.06% 119
2018
Q3
$215K Buy
+2,000
New +$200K 0.05% 120

Other funds holding LLY

Cabot Wealth Management's LLY Position: Q1 2026 in Review

Cabot Wealth Management reduced its Eli Lilly (LLY) stake by 2.1% in Q1 2026, selling an estimated $176K and leaving 8,200 shares worth $7.54M. The position accounts for 0.87% of the portfolio, ranked #43.

Cabot Wealth Management first reported a position in LLY in Q3 2018 and has held it in 31 quarters since. The position peaked at $9M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Cabot Wealth Management held 8,200 shares of Eli Lilly worth $7.54M as of Q1 2026.
  • Cabot Wealth Management sold 174 Eli Lilly shares in Q1 2026, an estimated $176K.
  • Eli Lilly made up 0.87% of Cabot Wealth Management's portfolio in Q1 2026, its #43 holding.
  • Cabot Wealth Management first reported a position in Eli Lilly in Q3 2018 and has held it in 31 quarters since.
  • Cabot Wealth Management's Eli Lilly position peaked at $9M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Cabot Wealth Management's 13F filing for Q1 2026, filed 27 Apr 2026.